Syngene International
-
Syngene International posts Rs 519 Cr PAT for the full year ending March 31, 2024
Fourth quarter revenue from operations declined 8 per cent year-on-year to Rs 917 cr, PAT increased 6 per cent to…
Read More » -
Syngene’s revenue from operations up 18.5 per cent to Rs 910 Cr
PAT (before exceptional items) up 20 per cent to Rs 122 crores Syngene International announced its second-quarter and half-year financial…
Read More » -
Syngene posts Rs 803 Cr revenue, PAT up to Rs 110 Cr
In manufacturing, the highlight of the quarter was the successful inspection of biologics facilities by the US FDA, EMA and…
Read More » -
Syngene in 10-year biologics manufacturing agreement with Zoetis
Syngene’s collaboration with Zoetis started in 2011 Syngene International announced the signing of a 10-year agreement with a leading animal…
Read More » -
Syngene posts Rs 2604 Cr revenue in Q4
Revenue from operations up 15 per cent to Rs 758 Cr in fourth quarter Syngene International announced its fourth-quarter and…
Read More » -
Syngene posts PAT of Rs 1,040 M in Q3
Revenue from operations grows by 10 per cent Syngene International announced its third-quarter results. The company reported revenue from operations…
Read More » -
Syngene International extends collaboration with Amgen till 2026
Under the extended contract, the dedicated R&D centre, ‘Syngene Amgen Research and Development Center’ will continue to conduct drug discovery…
Read More » -
Syngene expands biopharma-manufacturing capacity
Sets up a state-of-the-art microbial facility, expands mammalian facility Syngene International has announced the expansion of its biomanufacturing capacity. The…
Read More » -
Syngene announces senior-level appointments
Alan CollisAlex Del Priore was appointed as Senior Vice President, Manufacturing Services and Alan Collis appointed as Vice President, Integrated…
Read More »